nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.137	0.248	CbGbCtD
Rifabutin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.104	0.188	CbGbCtD
Rifabutin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0889	0.161	CbGbCtD
Rifabutin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0877	0.159	CbGbCtD
Rifabutin—CYP3A4—Prednisone—ankylosing spondylitis	0.0828	0.15	CbGbCtD
Rifabutin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0517	0.0937	CbGbCtD
Rifabutin—Burkitt's lymphoma—Methotrexate—ankylosing spondylitis	0.0349	0.196	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—EDIL3—ankylosing spondylitis	0.033	0.122	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—KIR3DL1—ankylosing spondylitis	0.0246	0.0908	CbGpPWpGaD
Rifabutin—HSP90AA1—NOD pathway—CARD9—ankylosing spondylitis	0.0218	0.0806	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—CRP—ankylosing spondylitis	0.0164	0.0607	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.0152	0.056	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.0106	0.0392	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.0105	0.0386	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.00753	0.0278	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00749	0.0277	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KIR3DL1—ankylosing spondylitis	0.00747	0.0276	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.00736	0.0272	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CARD9—ankylosing spondylitis	0.00673	0.0249	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.00654	0.0242	CbGpPWpGaD
Rifabutin—HSP90AA1—EBV LMP1 signaling—TNF—ankylosing spondylitis	0.00515	0.019	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.005	0.0185	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL1R2—ankylosing spondylitis	0.00452	0.0167	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ERAP1—ankylosing spondylitis	0.00429	0.0158	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HLA-C—ankylosing spondylitis	0.00423	0.0156	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CARD9—ankylosing spondylitis	0.00392	0.0145	CbGpPWpGaD
Rifabutin—Lymphopenia—Prednisone—ankylosing spondylitis	0.0039	0.022	CcSEcCtD
Rifabutin—Bacterial infection—Methotrexate—ankylosing spondylitis	0.00362	0.0204	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.00359	0.0133	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.00296	0.0109	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.00296	0.0109	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KIR3DL1—ankylosing spondylitis	0.00292	0.0108	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.00285	0.0105	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CARD9—ankylosing spondylitis	0.00263	0.00971	CbGpPWpGaD
Rifabutin—Aphasia—Methotrexate—ankylosing spondylitis	0.00257	0.0145	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—HLA-B—ankylosing spondylitis	0.0025	0.00924	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-C—ankylosing spondylitis	0.00246	0.0091	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00223	0.00825	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CRP—ankylosing spondylitis	0.00221	0.00817	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL1RN—ankylosing spondylitis	0.00214	0.00791	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—TLR4—ankylosing spondylitis	0.00212	0.00783	CbGpPWpGaD
Rifabutin—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.0021	0.0119	CcSEcCtD
Rifabutin—HSP90AA1—Disease—ANTXR2—ankylosing spondylitis	0.00204	0.00754	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL1A—ankylosing spondylitis	0.00193	0.00713	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD79A—ankylosing spondylitis	0.00188	0.00694	CbGpPWpGaD
Rifabutin—Skin discolouration—Methotrexate—ankylosing spondylitis	0.00185	0.0104	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—IL1R2—ankylosing spondylitis	0.00177	0.00653	CbGpPWpGaD
Rifabutin—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	0.00176	0.00994	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.0017	0.00627	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERAP1—ankylosing spondylitis	0.00167	0.00619	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HLA-C—ankylosing spondylitis	0.00165	0.0061	CbGpPWpGaD
Rifabutin—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00161	0.00909	CcSEcCtD
Rifabutin—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00156	0.00876	CcSEcCtD
Rifabutin—HSP90B1—Immune System—IL1A—ankylosing spondylitis	0.00154	0.00569	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CARD9—ankylosing spondylitis	0.00153	0.00566	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD40LG—ankylosing spondylitis	0.00153	0.00566	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-B—ankylosing spondylitis	0.00146	0.00538	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-A—ankylosing spondylitis	0.00135	0.00499	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CRP—ankylosing spondylitis	0.00129	0.00476	CbGpPWpGaD
Rifabutin—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00128	0.0072	CcSEcCtD
Rifabutin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00124	0.00701	CcSEcCtD
Rifabutin—HSP90B1—Immune System—TLR4—ankylosing spondylitis	0.00123	0.00456	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—B3GNT2—ankylosing spondylitis	0.0012	0.00444	CbGpPWpGaD
Rifabutin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00118	0.00666	CcSEcCtD
Rifabutin—Neutropenia—Prednisone—ankylosing spondylitis	0.00117	0.0066	CcSEcCtD
Rifabutin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00114	0.00644	CcSEcCtD
Rifabutin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00108	0.00609	CcSEcCtD
Rifabutin—Eye disorder—Betamethasone—ankylosing spondylitis	0.00108	0.00606	CcSEcCtD
Rifabutin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00108	0.00606	CcSEcCtD
Rifabutin—Convulsion—Prednisolone—ankylosing spondylitis	0.00104	0.00586	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00104	0.00584	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—B3GNT2—ankylosing spondylitis	0.00101	0.00372	CbGpPWpGaD
Rifabutin—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000995	0.0056	CcSEcCtD
Rifabutin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000986	0.00555	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—ankylosing spondylitis	0.000979	0.00551	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—HLA-B—ankylosing spondylitis	0.000976	0.00361	CbGpPWpGaD
Rifabutin—Shock—Prednisolone—ankylosing spondylitis	0.000965	0.00543	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—HLA-C—ankylosing spondylitis	0.000962	0.00355	CbGpPWpGaD
Rifabutin—Convulsion—Triamcinolone—ankylosing spondylitis	0.000957	0.00539	CcSEcCtD
Rifabutin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000955	0.00538	CcSEcCtD
Rifabutin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000941	0.0053	CcSEcCtD
Rifabutin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000939	0.00528	CcSEcCtD
Rifabutin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000939	0.00528	CcSEcCtD
Rifabutin—Eye disorder—Prednisone—ankylosing spondylitis	0.000937	0.00528	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000932	0.00525	CcSEcCtD
Rifabutin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000907	0.00511	CcSEcCtD
Rifabutin—Immune system disorder—Prednisone—ankylosing spondylitis	0.000906	0.0051	CcSEcCtD
Rifabutin—Shock—Triamcinolone—ankylosing spondylitis	0.000887	0.005	CcSEcCtD
Rifabutin—Insomnia—Prednisolone—ankylosing spondylitis	0.000887	0.00499	CcSEcCtD
Rifabutin—Shock—Methylprednisolone—ankylosing spondylitis	0.000885	0.00498	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000883	0.00497	CcSEcCtD
Rifabutin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000881	0.00496	CcSEcCtD
Rifabutin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000874	0.00492	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000871	0.00491	CcSEcCtD
Rifabutin—Convulsion—Betamethasone—ankylosing spondylitis	0.000869	0.00489	CcSEcCtD
Rifabutin—Convulsion—Dexamethasone—ankylosing spondylitis	0.000869	0.00489	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—CRP—ankylosing spondylitis	0.000863	0.00319	CbGpPWpGaD
Rifabutin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000854	0.00481	CcSEcCtD
Rifabutin—Myalgia—Betamethasone—ankylosing spondylitis	0.000854	0.00481	CcSEcCtD
Rifabutin—Pain—Prednisolone—ankylosing spondylitis	0.000839	0.00472	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000838	0.00472	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—IL1RN—ankylosing spondylitis	0.000835	0.00309	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—TLR4—ankylosing spondylitis	0.000827	0.00306	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000822	0.00463	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00082	0.00462	CcSEcCtD
Rifabutin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000816	0.00459	CcSEcCtD
Rifabutin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000814	0.00458	CcSEcCtD
Rifabutin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00081	0.00456	CcSEcCtD
Rifabutin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000808	0.00455	CcSEcCtD
Rifabutin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000808	0.00455	CcSEcCtD
Rifabutin—Anaemia—Prednisone—ankylosing spondylitis	0.000807	0.00454	CcSEcCtD
Rifabutin—Shock—Dexamethasone—ankylosing spondylitis	0.000805	0.00453	CcSEcCtD
Rifabutin—Shock—Betamethasone—ankylosing spondylitis	0.000805	0.00453	CcSEcCtD
Rifabutin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000804	0.00453	CcSEcCtD
Rifabutin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000801	0.00451	CcSEcCtD
Rifabutin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000801	0.00451	CcSEcCtD
Rifabutin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000794	0.00447	CcSEcCtD
Rifabutin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000792	0.00446	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000783	0.00441	CcSEcCtD
Rifabutin—Anorexia—Betamethasone—ankylosing spondylitis	0.00078	0.00439	CcSEcCtD
Rifabutin—Anorexia—Dexamethasone—ankylosing spondylitis	0.00078	0.00439	CcSEcCtD
Rifabutin—Pain—Triamcinolone—ankylosing spondylitis	0.000771	0.00434	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000757	0.00426	CcSEcCtD
Rifabutin—Convulsion—Prednisone—ankylosing spondylitis	0.000756	0.00426	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000745	0.0042	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000745	0.0042	CcSEcCtD
Rifabutin—Arthralgia—Prednisone—ankylosing spondylitis	0.000743	0.00419	CcSEcCtD
Rifabutin—Myalgia—Prednisone—ankylosing spondylitis	0.000743	0.00419	CcSEcCtD
Rifabutin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000743	0.00418	CcSEcCtD
Rifabutin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000741	0.00417	CcSEcCtD
Rifabutin—Insomnia—Betamethasone—ankylosing spondylitis	0.00074	0.00417	CcSEcCtD
Rifabutin—Insomnia—Dexamethasone—ankylosing spondylitis	0.00074	0.00417	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000738	0.00416	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000736	0.00414	CcSEcCtD
Rifabutin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000735	0.00414	CcSEcCtD
Rifabutin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000735	0.00414	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CD79A—ankylosing spondylitis	0.000733	0.00271	CbGpPWpGaD
Rifabutin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000722	0.00407	CcSEcCtD
Rifabutin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00072	0.00406	CcSEcCtD
Rifabutin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00072	0.00406	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000715	0.00402	CcSEcCtD
Rifabutin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000713	0.00401	CcSEcCtD
Rifabutin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000711	0.004	CcSEcCtD
Rifabutin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000711	0.004	CcSEcCtD
Rifabutin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000711	0.004	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000706	0.00398	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000706	0.00398	CcSEcCtD
Rifabutin—Shock—Prednisone—ankylosing spondylitis	0.000701	0.00395	CcSEcCtD
Rifabutin—Pain—Dexamethasone—ankylosing spondylitis	0.0007	0.00394	CcSEcCtD
Rifabutin—Pain—Betamethasone—ankylosing spondylitis	0.0007	0.00394	CcSEcCtD
Rifabutin—Skin disorder—Prednisone—ankylosing spondylitis	0.000692	0.0039	CcSEcCtD
Rifabutin—Anorexia—Prednisone—ankylosing spondylitis	0.000679	0.00382	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—ankylosing spondylitis	0.000674	0.0038	CcSEcCtD
Rifabutin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000674	0.0038	CcSEcCtD
Rifabutin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000674	0.0038	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000669	0.00377	CcSEcCtD
Rifabutin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000669	0.00377	CcSEcCtD
Rifabutin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000664	0.00374	CcSEcCtD
Rifabutin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000663	0.00373	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000653	0.00368	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000649	0.00366	CcSEcCtD
Rifabutin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000647	0.00364	CcSEcCtD
Rifabutin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000647	0.00364	CcSEcCtD
Rifabutin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000647	0.00364	CcSEcCtD
Rifabutin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000647	0.00364	CcSEcCtD
Rifabutin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000647	0.00364	CcSEcCtD
Rifabutin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000646	0.00363	CcSEcCtD
Rifabutin—Insomnia—Prednisone—ankylosing spondylitis	0.000644	0.00363	CcSEcCtD
Rifabutin—Paraesthesia—Prednisone—ankylosing spondylitis	0.00064	0.0036	CcSEcCtD
Rifabutin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000638	0.00359	CcSEcCtD
Rifabutin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000637	0.00358	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—ankylosing spondylitis	0.000632	0.00356	CcSEcCtD
Rifabutin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000627	0.00353	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000622	0.0023	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000622	0.0023	CbGpPWpGaD
Rifabutin—Chest pain—Methotrexate—ankylosing spondylitis	0.000621	0.0035	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—ankylosing spondylitis	0.000621	0.0035	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000621	0.0035	CcSEcCtD
Rifabutin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000619	0.00349	CcSEcCtD
Rifabutin—Rash—Prednisolone—ankylosing spondylitis	0.000618	0.00348	CcSEcCtD
Rifabutin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000618	0.00348	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000617	0.00347	CcSEcCtD
Rifabutin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000616	0.00347	CcSEcCtD
Rifabutin—Headache—Prednisolone—ankylosing spondylitis	0.000614	0.00346	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—IL1A—ankylosing spondylitis	0.000601	0.00222	CbGpPWpGaD
Rifabutin—Confusional state—Methotrexate—ankylosing spondylitis	0.0006	0.00338	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CD40LG—ankylosing spondylitis	0.000598	0.00221	CbGpPWpGaD
Rifabutin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000587	0.00331	CcSEcCtD
Rifabutin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000587	0.00331	CcSEcCtD
Rifabutin—Asthenia—Betamethasone—ankylosing spondylitis	0.000587	0.00331	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000583	0.00328	CcSEcCtD
Rifabutin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000583	0.00328	CcSEcCtD
Rifabutin—Nausea—Prednisolone—ankylosing spondylitis	0.000582	0.00328	CcSEcCtD
Rifabutin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000579	0.00326	CcSEcCtD
Rifabutin—Pruritus—Betamethasone—ankylosing spondylitis	0.000579	0.00326	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000578	0.00326	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000577	0.00213	CbGpPWpGaD
Rifabutin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000573	0.00323	CcSEcCtD
Rifabutin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000572	0.00322	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—HLA-B—ankylosing spondylitis	0.000569	0.0021	CbGpPWpGaD
Rifabutin—Rash—Triamcinolone—ankylosing spondylitis	0.000569	0.0032	CcSEcCtD
Rifabutin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000568	0.0032	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—ankylosing spondylitis	0.000568	0.0032	CcSEcCtD
Rifabutin—Rash—Methylprednisolone—ankylosing spondylitis	0.000567	0.00319	CcSEcCtD
Rifabutin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000567	0.00319	CcSEcCtD
Rifabutin—Headache—Triamcinolone—ankylosing spondylitis	0.000565	0.00318	CcSEcCtD
Rifabutin—Headache—Methylprednisolone—ankylosing spondylitis	0.000564	0.00317	CcSEcCtD
Rifabutin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000563	0.00317	CcSEcCtD
Rifabutin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000563	0.00317	CcSEcCtD
Rifabutin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00056	0.00315	CcSEcCtD
Rifabutin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00056	0.00315	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000543	0.00305	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—ankylosing spondylitis	0.000539	0.00303	CcSEcCtD
Rifabutin—Nausea—Triamcinolone—ankylosing spondylitis	0.000536	0.00302	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000535	0.00301	CcSEcCtD
Rifabutin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000534	0.00301	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000531	0.00299	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—HLA-A—ankylosing spondylitis	0.000527	0.00195	CbGpPWpGaD
Rifabutin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000525	0.00296	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000524	0.00295	CcSEcCtD
Rifabutin—Vomiting—Betamethasone—ankylosing spondylitis	0.00052	0.00293	CcSEcCtD
Rifabutin—Vomiting—Dexamethasone—ankylosing spondylitis	0.00052	0.00293	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000518	0.00291	CcSEcCtD
Rifabutin—Rash—Betamethasone—ankylosing spondylitis	0.000516	0.0029	CcSEcCtD
Rifabutin—Rash—Dexamethasone—ankylosing spondylitis	0.000516	0.0029	CcSEcCtD
Rifabutin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000515	0.0029	CcSEcCtD
Rifabutin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000515	0.0029	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000514	0.00289	CcSEcCtD
Rifabutin—Headache—Dexamethasone—ankylosing spondylitis	0.000513	0.00289	CcSEcCtD
Rifabutin—Headache—Betamethasone—ankylosing spondylitis	0.000513	0.00289	CcSEcCtD
Rifabutin—Asthenia—Prednisone—ankylosing spondylitis	0.000511	0.00288	CcSEcCtD
Rifabutin—Pain—Methotrexate—ankylosing spondylitis	0.000509	0.00287	CcSEcCtD
Rifabutin—Pruritus—Prednisone—ankylosing spondylitis	0.000504	0.00284	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CRP—ankylosing spondylitis	0.000503	0.00186	CbGpPWpGaD
Rifabutin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000491	0.00276	CcSEcCtD
Rifabutin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000488	0.00275	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000487	0.00274	CcSEcCtD
Rifabutin—HSP90AA1—Disease—HLA-A—ankylosing spondylitis	0.000487	0.0018	CbGpPWpGaD
Rifabutin—Nausea—Dexamethasone—ankylosing spondylitis	0.000486	0.00274	CcSEcCtD
Rifabutin—Nausea—Betamethasone—ankylosing spondylitis	0.000486	0.00274	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—TLR4—ankylosing spondylitis	0.000482	0.00178	CbGpPWpGaD
Rifabutin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000471	0.00265	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000471	0.00265	CcSEcCtD
Rifabutin—Vomiting—Prednisone—ankylosing spondylitis	0.000453	0.00255	CcSEcCtD
Rifabutin—Rash—Prednisone—ankylosing spondylitis	0.000449	0.00253	CcSEcCtD
Rifabutin—Dermatitis—Prednisone—ankylosing spondylitis	0.000449	0.00253	CcSEcCtD
Rifabutin—Headache—Prednisone—ankylosing spondylitis	0.000446	0.00251	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—TNF—ankylosing spondylitis	0.000442	0.00163	CbGpPWpGaD
Rifabutin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000439	0.00247	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—ankylosing spondylitis	0.000427	0.00241	CcSEcCtD
Rifabutin—Nausea—Prednisone—ankylosing spondylitis	0.000423	0.00238	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—ankylosing spondylitis	0.000421	0.00237	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000411	0.00152	CbGpPWpGaD
Rifabutin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000407	0.00229	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—ankylosing spondylitis	0.000379	0.00213	CcSEcCtD
Rifabutin—Rash—Methotrexate—ankylosing spondylitis	0.000375	0.00211	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000375	0.00211	CcSEcCtD
Rifabutin—Headache—Methotrexate—ankylosing spondylitis	0.000373	0.0021	CcSEcCtD
Rifabutin—Nausea—Methotrexate—ankylosing spondylitis	0.000354	0.00199	CcSEcCtD
Rifabutin—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	0.000212	0.000782	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	0.000163	0.000604	CbGpPWpGaD
